ARAY
What one share of Accuray Incorporated holds
Surgical and Medical Instruments and Apparatus
Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports treatment delivery, planning, imaging and data management solutions designed to help clinical teams deliver precise radiation treatments across a broad range of clinical cases.
Accuray Incorporated’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.28 |
|---|---|
| Profit | −$0.40 |
| Capex (buildings and equipment) | $0.05 |
| Free cash flow | −$0.10 |
| Cash and investments | $0.34 |
| Debt | $1.24 |
| Book value | $0.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $3.68 | $0.05 | $0.09 | −$0.17 | — | $2.95 |
| 2011 | $3.70 | −$0.44 | $0.07 | $0.14 | — | $3.43 |
| 2012 | $5.77 | −$1.02 | $0.15 | −$0.69 | — | $2.84 |
| 2013 | $4.31 | −$1.41 | $0.21 | −$1.11 | — | $1.43 |
| 2014 | $4.87 | −$0.47 | $0.16 | −$0.15 | — | $1.28 |
| 2015 | $4.85 | −$0.51 | $0.13 | −$0.32 | — | $0.95 |
| 2016 | $4.95 | −$0.32 | $0.10 | $0.28 | — | $0.73 |
| 2017 | $4.65 | −$0.36 | $0.06 | −$0.07 | — | $0.56 |
| 2018 | $4.77 | −$0.28 | $0.07 | $0.14 | — | $0.56 |
| 2019 | $4.79 | −$0.19 | $0.05 | −$0.39 | — | $0.56 |
| 2020 | $4.23 | $0.04 | $0.04 | −$0.06 | — | $0.70 |
| 2021 | $4.31 | −$0.07 | $0.03 | $0.39 | — | $0.76 |
| 2022 | $4.67 | −$0.06 | $0.05 | −$0.08 | — | $0.57 |
| 2023 | $4.72 | −$0.10 | $0.13 | $0.03 | — | $0.56 |
| 2024 | $4.54 | −$0.16 | $0.04 | −$0.16 | — | $0.45 |
| 2025 | $4.46 | −$0.02 | $0.04 | −$0.01 | — | $0.72 |
| 2026 | $3.28 | −$0.40 | $0.05 | −$0.10 | — | $0.35 |